Clinical Study | Office of Clinical Research

Randomized Phase II Trial Of Concurrent Chemoradiotherapy +/- Metformin Hcl In Locally Advanced Nsclc

Posted Date: May 15, 2019

Investigator: Jordan Kharofa
Type of Study: Drug

The purpose of this study is to compare any good and bad effects of using the anti-diabetic drug, metformin along with the standard of care radiation therapy and chemotherapy to using the standard of care radiation therapy and chemotherapy alone. The addition of metformin could shrink the cancer mor

Criteria:

To Be Eligible To Participate, Patients Must Have Advanced Lung Cancer Which Has Grown And Cannot Be

Keywords:

Cancer, Nsclc, Non-Small Cell Lung , Nrg-Lu001, Advanced

For More Information:

Uc Cancer Center
513-584-7698
kastla@uc.edu

Name*
First Last
Gender*
- Male
- Female
Age*
Phone*
Email*
How did you hear about us?*
Future Communication*
- By submitting this form, I am agreeing to receive future communication about participating in an upcoming research study.
CAPTCHA
This contact page is monitored Monday – Friday during business hours, 8 am to 5 pm EST. Do not rely on communication through this website for medical treatment or care. This website is not designed for such purposes.
For questions regarding clinical studies at UC Health, contact us at ResearchStudies@UCHealth.com or (513) 245-3417.
List